CorMedix Inc
NASDAQ:CRMD 3:59:50 PM EDT
Earnings Announcements
CorMedix Reports First Quarter 2022 Financial Results
Published: 05/12/2022 20:59 GMT
CorMedix Inc (CRMD) - .
Reports First Quarter 2022 Financial Results and Provides Business Update.
Q1 Loss per Share $0.18.
Believes That It Has Sufficient Resources to Fund Operations at Least Through First Half of 2023.
Reports First Quarter 2022 Financial Results and Provides Business Update.
Q1 Loss per Share $0.18.
Believes That It Has Sufficient Resources to Fund Operations at Least Through First Half of 2023.
Revenue is expected to be $0.03 Million
Adjusted EPS is expected to be -$0.21
Next Quarter Revenue Guidance is expected to be $0.03 Million
Next Quarter EPS Guidance is expected to be -$0.25
More details on our Analysts Page.
Adjusted EPS is expected to be -$0.21
Next Quarter Revenue Guidance is expected to be $0.03 Million
Next Quarter EPS Guidance is expected to be -$0.25
More details on our Analysts Page.